December 13, 2023 Xyloquinox Pharmaceuticals®, a pioneer in medical innovation, is pleased to announce the launch of their newest medication, GlucoReduxPlus™ (Glucotransmodulatine-XL), a revolutionary breakthrough in the treatment of Type 2 diabetes and weight management. This extraordinary drug is poised to transform the lives of millions, offering new hope and a more effective treatment strategy. GlucoReduxPlus™ has been heralded as…